
Syed Ali Naqvi
@syedynaqvi1
Interventional Cardiologist 🇮🇪 Alum: @stjamesdublin @UR_Med @PennMedicine @UniofGalway Tweets are my own
ID: 1416107890100875273
https://scholar.google.com/citations?user=Xz7IItoAAAAJ&hl=en&oi=ao 16-07-2021 18:50:28
5,5K Tweet
2,2K Followers
1,1K Following





Congrats Abbott Cardiovascular for U.S. FDA approval of #Tendyne #TMVR in MAC pts with mitral valve disease. This will be the first FDA approval of a TMVR device in the US. Thousands of implants have been done worldwide with 3-5y follow up on the longest survivors. Device is transapical




People do not understand that if 4,500 J1 doctors are removed THERE IS NO POOL OF 4,500 doctor lying around to replace them with. It also means around 500 programs will suddenly be competing for those available. And..... we have only THREE WEEKS till orientation Secretary Kennedy



Extremely important piece of information, here! A nice add-on to NOTION1 -10 years. Can we talk about a class effect? Looking forward to SMART RCT xiaowang and ideally 10 years😉. Davide Capodanno PCRonline 🫀





Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment ElevationOne-Year Outcomes of a Randomized Clinical Trial: JAMA Cardiology 🥸TOMAHAWK - and out of hospital cardiac arrest without STEMI 😱Here you go 👇👇👇👇



Good morning all. After yesterday's excitement about the CHALLENGE exercise trial, here is my critical appraisal on Sensible Medicine #ASCO25


Reevaluating Beta-Blocker Recommendations Post-Myocardial Infarction: Perspective on the 2025 Guideline Update: JACC Journals 🥸Commentary on the guidelines - early beta blocker use post MI - 😱Michael Nanna wrote extensively on this in older pts. 🥸Take a look 👇👇👇

